FindTrial
Sign In

Study on the application of Next-Generation Sequencing in the diagnosis of single-gene skin disease

Study on the application of Next-Generation Sequencing in the diagnosis of single-gene skin disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035389
Enrollment
Unknown
Registered
2020-08-09
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

single-gene skin disease

Interventions

Patients with single-gene skin disease and control group:Nill

Sponsors

Shanghai Skin Disease Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The corresponding clinical manifestations of single-gene skin disease, as well as the pathological diagnosis was confirmed at the same time; 2. Any age male and female; 3. Vital signs are stable; 4. The subject or guardian has signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. The patient has identified the mutated gene of single-gene skin disease; 2. At the discretion of the investigator, the subjects were either untrustworthy or poorly compliant.

Design outcomes

Primary

MeasureTime frame
Customized exon capture sequencing;—

Countries

China

Contacts

Public ContactYun BAI

Shanghai Skin Disease Hospital

baiyun@chgc.sh.cn+86 15801777141

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026